Should You Buy Theratechnologies Inc (THTX) Stock After it Has Fallen 34.21% in a Week?

Overall market sentiment has been down on Theratechnologies Inc (THTX) stock lately. THTX receives a Bearish rating from InvestorsObserver Stock Sentiment Indicator.

Theratechnologies Inc has a Bearish sentiment reading. Find out what this means for you and get the rest of the rankings on THTX!

See Full THTX Report

What is Stock Sentiment?

Sentiment uses short term technical analysis to gauge whether a stock is desired by investors. As a technical indicator, it focuses on recent trends as opposed to the long term health of the underlying company. Updates for the company such as a earnings release can move the stock away from current trends. Recent trends are a good indicator of current market sentiments. In its most basic form, stocks that are trending up are desirable by investors while stocks currently falling must be unattractive. InvestorsObserver's Sentimental Indicator tracks both changes in price and volume to analyze the most recent trends. Typically an increase in volume indicates ongoing trends are getting stronger, while a decrease in volume usually signals an end to the current trend. Available options can also represent current sentiments for a given stock. Since investors are able to bet on future trends of stocks using options, we consider the ratio of calls to puts when analyzing market sentiments .

What's Happening With THTX Stock Today?

Theratechnologies Inc (THTX) stock is trading at $1.00 as of 1:33 PM on Friday, Oct 27, a gain of $0.08, or 8.58% from the previous closing price of $0.92. The stock has traded between $0.92 and $1.02 so far today. Volume today is elevated. So far 408,865 shares have traded compared to average volume of 181,434 shares. To screen for more stocks like Theratechnologies Inc click here.

More About Theratechnologies Inc

Theratechnologies Inc is a specialty pharmaceutical company that addresses the unmet medical needs of HIV patients. It mainly operates in Canada and the United States. The company has two approved products, EGRIFTA marketed in Canada and the United States, and Trogarzo approved for commercialization in the United States. Click Here to get the full Stock Report for Theratechnologies Inc stock.